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Infective endocarditis (IE) is a life-threatening disease that is associated with highmorbidity andmortality. Its long-term prognosis
strongly depends on a timely and optimized antibiotic treatment. Therefore, identification of the causative pathogen is crucial and
currently based on blood cultures followed by characterization and susceptibility testing of the isolate.However, antibiotic treatment
starting prior to blood sampling or IE caused by fastidious or intracellular microorganismsmay cause negative culture results. Here
we investigate the additional diagnostic value of broad-range PCR in combinationwith direct sequencing on resected heart tissue or
swabs in patients with tissue or swab culture-negative IE in a routine clinical setting. Sensitivity, specificity, and positive and negative
predictive values of broad-range PCR fromdiagnosticmaterial in our patients were 33.3%, 76.9%, 90.9%, and 14.3%, respectively.We
identified a total of 20 patients (21.5%) with tissue or culture-negative IE who profited by the additional application of broad-range
PCR. We conclude that broad-range PCR on resected heart tissue or swabs is an important complementary diagnostic approach.
It should be seen as an indispensable new tool for both the therapeutic and diagnostic management of culture-negative IE and we
thus propose its possible inclusion in Duke’s diagnostic classification scheme.
1. Introduction
In spite of improvements in the diagnostic and treatment,
infective endocarditis (IE) remains a serious, life-threatening
disease [1–4] with an unchanged mortality rate up to 30%
and an incidence of 2 to 6 per 100,000 individuals per year
over the last 30 years [5]. The stagnation in mortality and
incidence can be ascribed to the progressively evolving pre-
disposing factors [6] leading to a change in the epidemiology
and etiology of IE, thereby resulting in worsening of the
individual course of IE [1, 5, 6]. Particularly noteworthy is
the general increase of reported health care associated IE
[7] with a potentially higher proportion of microorganisms
with a potentially complex resistance pattern. Especially
for S. aureus bloodstream infections, IE is referred to as
most frequent complication and occurs in 40% of patients
without heart disease [8]. Still, the primary sites of infec-
tion are native heart valves, but individuals with implanted
mechanical devices such as valvular prostheses, pacemakers,
or implantable defibrillators are increasingly involved [9–11].
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Early diagnosis of IE and rapid identification of the
causative pathogen are crucial for providing a specific and
efficient antibiotic therapy and improvement of the patient [5,
12–15]. Generally, in IE patients, blood cultures are frequently
positive [16]. Nevertheless, such cultures can remain negative
in 2.5% to 31% of all cases of IE, depending on causative
agent and the clinical circumstances [2, 17, 18]. Blood cultures
typically remain negative due to antibiotic therapy prior
or concurrent to blood sampling (∼50% of cases), due to
infection by fastidious organisms such as nutritionally variant
streptococci, fastidious Gram-negative bacilli of the HACEK
group (Aggregatibacter aphrophilus, former Haemophilus
aphrophilus and H. paraphrophilus; Aggregatibacter actino-
mycetemcomitans, formerActinobacillus actinomycetemcomi-
tans; Cardiobacterium hominis; Eikenella corrodens; Kingella
kingae), Brucella spp. (in endemic areas), and fungi or due to
infections by intracellular bacteria such as the zoonotic agents
Coxiella burnetii and Bartonella and Tropheryma whipplei
[5]. In such cases, negative cultures may significantly delay
diagnosis and effective treatment which possibly negatively
impacts on the outcome of the patient [17].
These obvious drawbacks of conventional techniques
clearly impair the current criteria used for clinical diagnosis
of IE and call for adjunctive diagnostic methods increas-
ing the sensitivity for more rapid pathogen recovery and
identification. This is why in such cases of blood culture-
negative or clinically questionable IE, culture-independent,
new molecular diagnostic techniques such as broad-range
polymerase chain reaction (PCR) with subsequent DNA-
sequencing fromheart valve specimenhave gained increasing
attention and were shown to be useful in the detection and
classification of bacterial DNA in several recent diagnostic
studies [19–28]. Besides detecting organisms that are missed
by culture-dependent methods, PCR-based methods also
allow exact identification of the causative organism and the
identification of new hitherto unknown pathogens causing IE
even if the patient is already under antibiotic treatment [29].
These possibly beneficial features of broad-range PCR for the
diagnosis in such cases have even led to the proposition of
PCR positivity as a major diagnostic criterion for IE [14, 19,
30]. However, further research is clearly required until PCR-
based methods become accepted as routine diagnostic tool
[2, 9].
The aim of the present study was to investigate the
additional diagnostic value of broad-range PCR targeting the
16S ribosomal DNA in heart tissue or swabs in patients with
confirmed, suspected, or possible IE in a routine clinical
diagnostic setting. We hypothesized that the use of broad-
range PCR amplification followed by direct sequencingmight
increase the number of identified causative pathogens in cases
with culture-negative IE and in antibiotically pretreated indi-
viduals thereby possibly improving the rapidity of diagnosis
in such patients also in the routine diagnostic setting.
2. Material and Methods
2.1. StudyDesign and Patients. For our retrospective observa-
tional study, we identified all patients admitted to Kerckhoff
Clinic in Bad Nauheim (Germany), between 2011 and 2014
(Figure 1).This cohort was then subjected to further in-depth
computer-assisted analysis identifying all patients admitted
with a diagnosis of suspected or definite infective endocardi-
tis encoded by the ICD-10-GM (International Classification
of Diseases, 10th Revision, German Modification) for “acute
and subacute endocarditis” (I.33.-) and undergoing cardio-
surgical treatment. We also looked for all patients subjected
to diagnostic testing after admission to Kerckhoff Clinic by
broad-range PCR amplification and direct sequencing from
cardiosurgical specimens as performed at the Institute of
Laboratory Medicine, Microbiology and Infection Control at
the NorthwestMedical Centre in Frankfurt/Main (Germany)
during the same time period. In combining both selectors,
all patients were identified with both an encoded diagnosis
of “acute and subacute endocarditis” and a diagnostic test
result of broad-range PCR and direct sequencing from
cardiosurgical specimens for further investigation (Figure 1).
Medical charts of all patients of this study group were
then retrospectively reviewed and patients were included
in the study if both the microbiological findings or broad-
range PCR and the corresponding tissue or swab culture of
cardiosurgical specimens were available.
2.2. Definition of Diagnosed IE. For the purpose of this study,
patients of the study group were divided into three different
categories (“definite,” “possible,” and “no evidence for” IE;
Figure 1) according to somemodification ofDuke’s criteria for
the diagnosis of IE [31] and including all available data from
the medical charts at Kerckhoff Clinic as follows: definite IE:
a typical valve histopathology (considered as gold standard)
in addition to 2 or more findings indicating IE in any of
the following diagnostic procedures is present: echocardio-
graphy, preoperative BC (preBC), and typical intraoperative
macroscopic aspect; possible IE: there is negative valve
histopathology or evidence for IE resulting from one of the
above-mentioned diagnostic procedures only, but there is a
positive result upon PCR and/or tissue or swab culture from
valve tissue after surgery; no evidence for IE: only one of
the above described procedures provided evidence for IE but
PCR, conventional culture fromvalve tissue after surgery, and
histopathology proved negative (Figure 1).
2.3. Surgical Material. Tissue specimens or swabs from
intraoperatively excised cardiac tissue were taken during
cardiosurgical treatment at Kerckhoff Clinic in Bad Nauheim
according to local standard surgical and diagnostic proce-
dures, and specimens for microbiological analysis were then
delivered to the Institute of Laboratory Medicine, Microbiol-
ogy and Infection Control at the Northwest Medical Centre
in Frankfurt/Main (Germany) for microbiological analysis
performed under standard conditions.
2.4.MolecularMethods. Bacterial DNAwas isolated from the
intraoperative excised specimens by means of the MagNA
Pure Compact System (Roche Diagnostics, Mannheim, Ger-
many). For the amplification of the 16S-rDNA with a
GeneAmp PCR System 2700 or a Thermal Cycler 2720
(Applied Biosystems, Darmstadt, Germany), the universal
5󸀠 primer 285 (gag agt ttg atc ctg gct cag, position 9–29
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Cohort of patients admitted to the Kerckhoff Clinic between
January 2011 and April 2014 
Patients encoded with
ICD “acute and subacute
endocarditis”
Patients whose cardiosurgical
specimens were analyzed by
broad-range PCR 
Patients with diagnosis encoded by ICD “acute and
subacute endocarditis” and PCR diagnostic findings of
cardiosurgical specimen
Definite Possible No evidence
N = 10N = 4N = 100
N = 114
N = 122N = 210
N = 40,190
Classification of diagnosis of IE according to clinical
and laboratory findings
Figure 1: Overview of the assortment of the study group. Workflow scheme for the assortment of patients according to the criteria described
in detail in Section 2.
within gene according to 16S-rDNA of Escherichia coli) and
the universal 3󸀠 primer 243r (acg agc tga cga cag cca tg,
E. coli position 1073–1054) (both primers synthesised by
TiB Molbiol, Berlin, Germany) were used [32]. From visible
UV-bands PCR products were purified with the QIAquick
PCR Purification Kit (50/250) (QIAGEN, Hilden, Germany).
Sequencing was carried out using a BigDye Terminator v.1
or alternatively using a BigDye Terminator v3.1 (Applied
Biosystems, Darmstadt, Germany) according to the manu-
facturer’s instructions. Analysis of the sequencing products
was carried out using ABI 3500 Dx Sequencer (Applied
Biosystems, Darmstadt, Germany). For the identification
of the pathogens, the resulting sequences were then com-
pared with reference sequences obtained from the NCBI
database using BLAST (Basic Local Alignment Search Tool,
http://blast.ncbi.nlm.nih.gov/).
3. Results
3.1. Assortment of Patients. In our observational retrospective
study, we identified a total of 40,190 patients admitted to
Kerckhoff Clinic in Bad Nauheim between January 2011 and
April 2014. A total of 114 patients with suspected or diagnosed
IE who underwent cardiosurgical treatment during this time
4 BioMed Research International
Table 1: Distribution of types of valves infected within the study
group.
Type of valve infected (𝑁 = 113∗)





𝑁 (%) 73 (64.6) 34 (30.1) 6 (5.3)
104 patients; F/M ratio 1 : 3; mean age 66.0 ± 12.6 years
∗Heart valves of patients with two infected heart valves are counted
separately.
period were included in our study. One hundred patients had
definite IE and 4 patients had possible IE according to our
above defined criteria. For 10 patients there was no evidence
for the clinically suspected diagnosis of IE. The patients with
definite or possible IE (𝑛 = 104) were included in our further
analysis whereas the 10 patients with no definite evidence for
IE were excluded and used for the computation of sensitivity,
specificity, and positive and negative predictive values only.
The incidence of IE in our cohort of admitted hospital
patients was found to be 259 per 100,000 patients/year.
3.2. Description of Patients and Surgical Material. Out of 104
selected patients with possible or definite IE, 75weremen and
29 were women (F/M ratio: ∼1 : 3) with a mean age of 66.0 ±
12.6 years. The primary sites of infection were native heart
valves (64.6%) with 37 aortic (50.7%), 34 mitral (46.6%), and
2 tricuspid (2.7%) valves. 30.1% were prosthetic valves (aortic
valve, 𝑛 = 28, 82.4%; mitral valve, 𝑛 = 5, 14.7%; and tricuspid
valve, 𝑛 = 1, 2.9%) whereas 5.3% showed infected cardiac
devices (𝑛 = 6) (Table 1). Nine of the 104 patients suffered
from two infected heart valves or an infected valve together
with an infected cardiac device (aortic/mitral valve, 𝑛 = 7;
prosthetic aortic/mitral valve, 𝑛 = 1; mitral valve/cardiac
device, 𝑛 = 1) according to the diagnosis documented in the
medical charts (Table 1).
3.3. Comparison of PCR Results with Clinical Findings. Bac-
terial broad-range PCR amplification was positive in 40
samples (38.5%) obtained from 104 patients with possible
or definite diagnosis of IE. In 36 of 100 patients (36.0%)
PCR results showed analytical agreement with the clinically
defined diagnosis of definite IE. In 4 patients with possible
IE that lacked clinical diagnostic evidence, broad-range PCR
from valve tissue yielded a positive result supporting the
clinical suspicion (Table 2, Figure 2).
In 33 of the 40 patients with positive PCR amplification
(82.5%), sequencing of the amplicons was possible up to the
species level and identified mainly streptococci and entero-
cocci (both 𝑛 = 9, 27.2%), followed by staphylococci (𝑛 = 8,
24.2%) and sporadically occurring pathogens (𝑛 = 7, 21.2%).
Themajority of the streptococcal sequences were identified as
streptococci of the viridans group (𝑛 = 7, 77.8%), for example,
S. mitis and S. gordonii. Among the staphylococci, S. aureus
was identified most frequently (𝑛 = 4, 50%). Among the
sporadically occurring bacteria, Aerococcus urinae (𝑛 = 1),
Anoxybacillus spp., Bartonella quintana (𝑛 = 1), Gemella
haemolysans (𝑛 = 1), Granulicatella adiacens (𝑛 = 1), and
Propionibacterium acnes (𝑛 = 2) were found (Table 3).
In the remaining 7 (17.5%) of the 40 patients with positive
broad-range PCR, sequencing was not possible due to a
mixture of DNA belonging to different organisms (𝑛 = 4,
57.1%) or due to low DNA concentrations (𝑛 = 3, 42.9%) in
the sample. At least 33 of the 40 PCR-positive patients were
treated with antibiotics preoperatively; for the remaining 7
patients these data were not available.
In 64 of 100 specimens, PCR amplification was negative
despite the clinically confirmed diagnosis of IE in those
patients. At least 60 of these 64 negative tested patients
(93.8%) received antibiotics before surgery. For the 10 patients
without clinical evidence for IE, PCR amplification was
negative and further confirmed the absence of IE (Table 2).
3.4. Comparison of PCR Results with Preoperative Blood
Cultures. Data of preBC were available for 82 of the 104
patients (78.8%) among which 71 were positive (86.6%) and
11 were negative (13.4%). Staphylococci were detected most
frequently with 35.5% (𝑛 = 27), followed by streptococci (𝑛 =
24, 31.6%), enterococci (𝑛 = 13, 17.1%), and other (𝑛 = 12,
15.8%). On species level 63.0% were Staphylococcus aureus
(𝑛 = 17) one of which was methicillin-resistant S. aureus
(MRSA). 66.7% of the streptococci (𝑛 = 16) were represented
by streptococci of the viridans group; for a detailed overview
see Figure 2.
Of the 71 positive preBC, 27 were confirmed by positive
broad-range PCR amplification results (38.0%). However, in
14 cases (52%) the pathogens identified differed between both
techniques on genus and/or species level (see Table 3). In
one patient where preBC identified two species of bacteria
(E. coli and Streptococcus mitis), the presence of more than
one species was confirmed by broad-range PCR which
identified a DNA mixture in the sample. In the remaining
44 of the 71 blood culture-positive cases (62.0%), broad-
range PCR was negative. 43 of these patients with blood
culture-positive but PCR-negative results (97.7%) received
preoperative antibiotics. Only 1 of the 11 blood culture-
negative patients (9.1%) had a positive PCR result. In the
remaining 10 patients with blood culture-negative results,
PCR results were consistent. All of these patients were treated
with antibiotics preoperatively (Figure 2).
3.5. Comparison of PCR Results with Results of Tissue or Swab
Culture. Broad-range PCR was positive in 40 of 104 patients
with definite or possible IE (38.5%) but at least 33 patients of
those PCR-positive IE received antibiotics preoperatively. For
the remaining 7 patients data about preoperative antibiotic
treatment were not available (Table 2).
In 11 patients, broad-range PCR was performed excep-
tionally before having obtained a negative result of tissue
or swab culture upon special clinical request. Seven of
the culture-positive cases (63.6%) were concordant with a
positive broad-range PCR, whereas 4 cases (36.4%) showed
a negative PCR result. Among the cases with both a positive
BioMed Research International 5
Table 2: Overview of PCR results and preoperative antibiotic treatment. Crude numbers refer to number of patients; numbers in parentheses
indicate the proportion of valve tissue samples versus swabs.
Tissue samples/swabs1
Number of patients PCR
Positive Negative
Total 114 40 (28/12) 74 (42/32)
Preoperative antibiotic treatment 101 33 ∗ND 7 68 ∗ND 4
IE
Definite 100 36 (25/11) 64 (35/29)
Possible 4 4 (3/1) 0
No evidence 10 0 10 (7/3)
∗ND: no data available; for 2 patients a preoperative antibiotic treatment could be excluded by medical chart.
1Positive tissue/swab cultures were available for 11 specimens that were exceptionally analyzed using broad-range PCR before a negative culture result was





definite/possible IE PCR results
Staphylococcus,
thereof S. aureus 63%,
Streptococcus,





(for more details see Table 3)
∗The detected amplicon could not be sequenced due to detection of more than one organism or low DNA content.
Add-on n = 9
Add-on n = 1
pos n = 12
pos n = 1
pos n = 27
neg n = 44
neg n = 10
neg n = 10
No sequencing ∗n = 4
n = 33
No sequencing ∗n = 3
Concordance n = 9
Discordance n = 14





Figure 2: Comparative presentation of PCR results with preoperative blood culture. Bars represent on a percentage basis the distribution
of preoperative blood culture results (preBC), correlated with the results of PCR followed by direct sequencing. Blue shaded bars represent
negative results or no available information. Red shaded bars represent a positive result in blood culture or PCR amplification. In the column
on the right hand side further information is provided. The results of direct sequencing are classified according to either a concordance or
discordance in comparison to the results of blood culture or as add-on information in case of a negative or not available result. An in-depth
detailed comparison is additionally shown in Table 3.
culture and PCR result, the identified pathogens differed
among both techniques in 2 cases where broad-range PCR
identified Streptococcus gordonii and Streptococcus gallolyti-
cus whereas tissue or swab culture revealed Staphylococcus
epidermidis and Staphylococcus pasteuri suggesting possible
contamination of culture (Table 4). Nevertheless, these data
were described only but not used for the computation of
sensitivity, specificity, and positive and negative predictive
values of broad-range PCR.
Of the 33 culture-negative cases (Table 5), the identifi-
cation of the causative pathogens by broad-range PCR was
possible in 26 specimens (78.7%) and revealed predominantly
streptococci [𝑛 = 7, 21.2%], followed by enterococci and
staphylococci [both 𝑛 = 6, 18.2%]. For 7 specimens [21.2%],
sequencing of the PCR products could not identify the
etiology of the pathogens due to the presence of a DNA
mixture or too low DNA concentrations in the sample.
3.6. Sensitivity, Specificity, and Positive andNegative Predictive
Value of Broad-Range PCR. For the computation of the
sensitivity, specificity, and positive and negative predictive
values of broad-range PCR performed on tissue or swab
specimens in tissue or swab culture-negative patients, all
patients of the study (with definite, possible, and no evidence
for IE) with a negative tissue or swab culture were included
(𝑛 = 103).
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Table 4: Comparison of PCR with results of tissue or swab culture. For a small patient group (𝑛 = 11) results of both methods (PCR
amplification and culture of swab or tissue) were exceptionally gained upon special clinical request.The direct comparison is provided in this
table; these data were not used for further computation of sensitivity, specificity, and positive and negative predictive values of broad-range
PCR.
Result Culture PCR
Positive in both methods,
concordance on species level
𝑛 = 5





Staphylococcus epidermidis Streptococcus gordonii
Staphylococcus pasteuri Streptococcus gallolyticus
Culture positive but PCR amplification
negative
𝑛 = 4
2 × Enterococcus faecium neg
Staphylococcus aureus neg
Coagulase-negative staphylococci neg
Table 5: Frequencies and etiology of causative pathogens identified
by broad-range PCR in tissue or swab culture-negative IE patients
(𝑛 = 33).
Causative pathogens identified
by PCR in culture-negative IE 𝑛 %
Aerococcus urinae 1 3.0
Anoxybacillus spp. 1 3.0
Bartonella quintana 1 3.0
Enterococci 6 18.2
Gemella haemolysans 1 3.0
Granulicatella adiacens 1 3.0
Propionibacterium acnes 2 6.1
Staphylococcus aureus 4 12.1
Staphylococcus epidermidis 2 6.1
Streptococci 7 21.2
No sequencing possible 7 21.2
Total 33 100
Sensitivity and specificity of the broad-range PCR per-
formed in cardiac tissue or swab specimens in tissue or swab
culture-negative IE were 33.3% (23.8–44.1%; 95% interval)
and 76.9% (46.2–94.7%), respectively, whereas the positive
and negative predictive values of the broad-range PCR
were 90.9% (75.6–98.0%) and 14.3% (7.1–24.7%), respectively
(Table 6).
4. Discussion
Despite advances in diagnostic and therapeutic proce-
dures, infective endocarditis remains a serious [1–3], life-
threatening disease where long-term prognosis strongly
depends on an immediate and optimized antibiotic treat-
ment. Therefore besides an early establishment of the diag-
nosis, the rapid and correct identification of the causative
microorganism is particularly important for the patient’s
prognosis [13, 33]. Currently, blood cultures remain the diag-
nosticmainstay for identification and species-specific charac-
terization of IE-associated pathogens also because they offer
the possibility of antimicrobial susceptibility testing for target
Table 6: Calculation of sensitivity, specificity, and positive and
negative predictive values. Calculation of sensitivity, specificity, and
positive and negative predictive values is based on a dataset of 𝑛 =
103. The gold standard is defined according to the criteria outlined




+ 30 3 90.9% Positivepredictive value
− 60 10 14.3% Negativepredictive value
33.3% 76.9%
Sensitivity Specificity
directed antimicrobial treatment. If antibiotic treatment,
however, is started prior to or concurrent to blood sampling
or if IE is caused by slow-growing, fastidious or intracellular
microorganisms, blood cultures may yield negative results [2,
18] which may lead to inadequate treatment and worsening
of the patient. Here, molecular methods such as broad-
range PCR amplification followed by direct sequencing of
bacterial DNA performed in excised heart valve tissue hold
promise in revealing the etiology of culture-negative IE. The
broader diagnostic value of PCR for routine microbiological
diagnostics, however, needs further evaluation until these
techniques may become more generally accepted [13]. In this
retrospective study, we, therefore, investigated the possible
additional value of broad-range PCR amplification followed
by direct sequencing performed in resected heart tissue or
swabs for diagnosing IE in 104 patients with suspected or
diagnosed IE in a routine clinical setting.
The incidence of IE in our cohort was found to be 2.6 per
1,000 patients per year which is much higher than reported
in the general population (∼2–6 per 100,000 individuals
per year) [5] due to the fact that we focused on patients
admitted to a specialized clinic for cardiac surgery. The
patients included in our study still reflect the changing
epidemiology of IE described in the literature [5] with a
high mean age of 66.0 years. Also, men were affected more
often than women (∼3 : 1) and besides native heart valves
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(64.6%) we observed an increased number of infections
of prosthetic valves (30.1%) and cardiac devices (5.3%) as
the primary site of infection [11]. The number of infected
prosthetic valves in our study is higher than described in
recent investigations [5]. This may again be explained by the
selection of our study population from individuals admitted
for cardiac surgery which is indicated in case of progressive
prosthetic valve endocarditis [34]. Relating to the microbial
spectrum, all microorganisms identified corresponded to
commonly known pathogens causing IE [16] except for one
isolate of Anoxybacillus spp. detected by broad-range PCR
and two identified by blood culture only (S. alactolyticus and
S. auricularis).
Considering mainly clinical findings as the gold standard
for diagnosing IE, the sensitivity and specificity of broad-
range PCR performed in resected heart valve tissue or
swabs to diagnose IE in heart valve tissue or swab culture-
negative IE were 33.3% and 76.9%, respectively, whereas
the positive and negative predictive values were 90.9% and
14.3%, respectively. In our study, broad-range PCR testing
was only applied when tissue or swab culture from resected
heart tissue remained sterile. Thus, for the evaluation of the
accuracy of broad-range PCR in diagnosing IE, only patients
with tissue or swab culture-negative IE were considered.
This is probably why values of specificity, sensitivity, and
positive and negative predictive values were somewhat lower
than those reported in other studies (ranges: sensitivity: 41.2
to 96.0%, specificity: 95.3–100%, positive predictive value:
98.4–100%, and negative predictive value: 26.2–88.5%) [14,
19, 24, 25, 35]. Additionally, when comparing such values
it should be kept in mind that not all of these studies
were performed in a routine clinical setting. In contrast
to classical prospective study conditions routine application
may impair the elaborateness of preanalytical conditions and
the management of practical procedures such as sampling
and handling of the resected material which can negatively
impact on the outcome. In this study, broad-range PCR was
performed not only on resected heart tissue as the preferred
analyticalmaterial but also on clinical swabs taken fromheart
tissue that are known for a lower recovery rate. Moreover
the type of tissue biopsied may be crucial, with vegetations
more likely than heart valves to yield a positive PCR product
[36, 37]. Also differences in study design, method applied,
and prolonged antibiotic treatment periods before surgery
may explain our relatively lower broad-range PCR sensitivity
compared to other studies. In fact, at least 93.8% of patients
with negative broad-range PCR received antibiotics before
surgery. Broad-range PCR test results can turn negative more
quickly than histopathological or gross evidence of IE [38]
which can lead to discrepancies between PCR and other
diagnostic methods when applying nucleic amplification
techniques. Nevertheless, the high positive predictive value
of PCR in our study shows that broad-range PCR on resected
heart tissue or swabs is a reliable method to diagnose IE
in culture-negative patients as in 90.9% of all patients with
positive test results it further confirmed the presence of IE,
whereas the low negative predictive value of 14.3% indicates
that a negative PCR result apparently cannot exclude IE.
For 4 patients in whom the diagnosis of IE could not
be established by clinical evidence alone, broad-range PCR
provided the etiologic diagnosis of IE, thereby confirming
the suspicion of IE. If broad-range PCR had been primarily
accepted as a specific diagnostic criterion, as proposed by
some [19, 21, 24], these cases of “possible IE” would have
been reclassified as “definite IE” which would have increased
the sensitivity and positive predictive value of PCR in our
investigation.
The majority of the patients with definite and possible IE
of whom data of preBC were available (78.8%) had a positive
blood culture (86.6%). In only 38.0% of these patients, broad-
range PCRwas positive. In one-third of these patients (𝑛 = 9)
with a positive blood culture and a broad-range PCR, the
microorganisms identified differed among both techniques in
both the species and the genera. In two of these cases, blood
culture revealed S. alactolyticus and S. auricularis which
are not reported in literature to cause IE whereas broad-
range PCR identified microorganisms (S. gallolyticus and S.
aureus, resp.) consistent withmicroorganisms causing IE [39]
pointing to possible misidentification or even contamination
of blood cultures in these cases. In two other cases, broad-
range PCR identified fastidious bacteria such as Granuli-
catella adiacens and the intracellular organism Bartonella
quintanawhich can be easily missed by conventional culture-
based methods [13, 36, 40]. In the latter case conventional
culture revealed S. epidermidis which can be clearly assumed
to be a contamination in the clinical context. For 2 cases
in which blood culture revealed the genus only, broad-
range PCR identified the species of the bacteria and thereby
specified the etiology of the causative microorganisms. All
these cases represent a possible diagnostic “add-on” of PCR
diagnostics as the molecular identification of the causative
pathogen by broad-range PCR is regarded more accurately
than by blood culture and biochemical identification [41].
Furthermore, broad-range PCR from valve tissue is known to
bemore specific in the etiologic diagnosis of IE and, therefore,
may also lead to better tailored treatment regimens after IE
and cardiac surgery.
In the majority of blood culture-positive cases, broad-
range PCR remained negative (62.0%) which can be ascribed
either to prolonged preoperative antibiotic treatment as 97.7%
of these patients received antibiotics before surgery or to
possible inadequate intraoperative specimen collection. This
is why several fractions of the valve tissue should best be
collected for broad-range PCR [22, 36] and swabs should
be avoided. In one case out of 11 blood culture-negative IE
cases (9.1%), broad-range PCR provided the sole etiologic
diagnosis of IE. Although in the routine clinical setting the
sensitivity of PCR testing was somewhat lower than expected,
our study confirms the usefulness of PCR amplification and
sequencing of the bacterial 16S-rDNA as an important add-
on technology in the analysis of resected heart valve tissue
of swabs in cases with tissue or swab culture-negative IE as
described previously [19, 21, 24, 28]. Our study identified a
total of 20 patients (21.5%) who possibly profited from the
application of broad-range PCR in case of heart tissue or
swab culture-negative IE by the following: (i) reclassifying a
“possible IE” to “definite IE” considering broad-range PCR
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as a criterion for IE (15.0%); (ii) providing the sole etiologic
identification of the causative pathogen (25.0%); (iii) correc-
tion of genera and species of probably misidentified causative
pathogens resulting from preBC diagnostics (35.0%); (iv)
adding the correct species identification specification to the
pathogen identified by preBC (20.0%); and (v) excluding pos-
sible contaminants resulting from preBC diagnostics (5.0%).
5. Conclusion
Novel perspectives on the management of IE are needed
to decrease the rate of residual deaths by accelerating the
processes of diagnosis, risk stratification, and facilitating the
individualised adaption of antimicrobial therapy. In view of
our results we, thus, consider broad-range PCR on resected
heart valve tissue as a helpful supplementary tool in patients
with culture-negative or questionable IE. Further research
into the “added value” of broad-range PCR in the diagnosis of
IE, compared to conventional diagnostics in routine clinical
settings, as well as a better standardization and further
improvements of PCR technology including increased sen-
sitivity and specificity are necessary before this technique
can be finally included in Duke’s classification scheme.
Nevertheless, culture-dependent methods will remain the
mainstay in the diagnosis of IE as they offer the possibility of
antimicrobial susceptibility testing of the causative pathogen.
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Maladies Infectieuses, vol. 45, no. 1-2, pp. 1–8, 2015.
[31] J. S. Li, D. J. Sexton, N. Mick et al., “Proposed modifications
to the Duke criteria for the diagnosis of infective endocarditis,”
Clinical Infectious Diseases, vol. 30, no. 4, pp. 633–638, 2000.
[32] U. Edwars, T. Rogall, H. Blocker, M. Emde, and E. C. Bottger,
“Isolation and direct complete nucleotide determination of
entire genes. Characterization of a gene coding for 16S riboso-
mal RNA,”Nucleic Acids Research, vol. 17, no. 19, pp. 7843–7853,
1989.
[33] W.-L. Cheng, C. W. Li, M. C. Li, N. Y. Lee, C. C. Lee, and W. C.
Ko, “Salmonella infective endocarditis,” Journal of Microbiology,
Immunology and Infection, 2015.
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